Drawing for MDP+

USPTO serial 98680696

MDP+

Reviewed by CopyMark Law Group

Status 601
Filing date
Status date
Registration date
—
Examiner
HOWARD, PARKER WALDRIP
Law office
TMO LAW OFFICE 127

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with MDP+?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Richard Y. Kim

Richard Y. Kim Snell & Wilmer L.L.P.One East Washington Street, Suite 2700Phoenix, AZ 85004-2556United States

Goods and services

ClassDescriptionStatusFirst use
005Pharmacological preparations in the nature of medicated skin care preparations; transdermal patches for use in the treatment of dermatological conditions, dermatological diseases and dermatological disorders; plasters for medical purposes; adhesive transdermal patches for use in the treatment of dermatological conditions, dermatological diseases and dermatological disorders; injectable dermal fillers; implantable medicines, namely, medicines for the treatment of dermatological conditions, dermatological diseases and dermatological disorders; skin hydrators being injectable dermal fillers; medicated creams for dermatological use; medicated preparations for skin treatment; medicated pre-moistened tissues and wipes; medicated anti-bacterial face washes; scrubs for medical use in the nature of preparations for cleansing the skin for medical use; face scrubs in the nature of medicated facial cleansers; medicated acne creams; acne cleansers in the nature of medicated creams for treating dermatological acne conditions; nutraceuticals for use as dietary supplementsABANDONED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Apr 10, 2025MAB1ABANDONMENT NOTICE E-MAILED - EXPRESS ABANDONMENT—
Apr 10, 2025ABN1ABANDONMENT - EXPRESS MAILED—
Apr 9, 2025EXARTEAS EXPRESS ABANDONMENT RECEIVED—
Apr 2, 2025CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Apr 1, 2025TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Apr 1, 2025CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Apr 1, 2025TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 21, 2025GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 21, 2025GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 21, 2025CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 19, 2025DOCKASSIGNED TO EXAMINER—
Feb 18, 2025NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Aug 2, 2024NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance